Malaysian Research Center Frees Nation From Relying On Foreign Labs
This article was originally published in PharmAsia News
A new Malaysian research facility aims to free the nation of reliance on foreign laboratories to find treatments for infectious tropical diseases
You may also be interested in...
Discovered at record-breaking speed by AbCellera, Lilly says the antibody candidate could progress into Phase II trials by June.
The European Medicines Agency’s clinical data publication policy is on hold, but calls are growing for the regulator to start publishing trial data for COVID-19 treatments and vaccines as soon as they are authorized in the EU.
Facing the aftermath of coronavirus disruption and supply chain reorganization, executives of multinational drug firms in China say the government needs to do more to help address a flurry of issues laid bare by the public health crisis.